Clinical Trials Directory

Trials / Completed

CompletedNCT00440869

Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis

Effects of N-acetylcysteine on Muscle Fatigue in ESRD

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purposes of the study are to determine whether oxidative stress causes the muscle of dialysis patients to tire more quickly than muscle of people without kidney disease and to determine whether treatment with N-acetylcysteine, an antioxidant, can improve muscle endurance.

Detailed description

Muscle dysfunction is a major problem for patients with end-stage renal disease (ESRD). Specifically, these patients experience approximately three-fold greater muscle fatigue of the lower extremities during intermittent submaximal contractions than healthy control subjects. Thus, a treatment that could ameliorate muscle fatigue in this population has the potential to increase endurance during activities of daily living and improve quality of life. Dialysis patients have been shown to have high levels of various markers of oxidative stress, and oxidative stress has been associated with excessive muscle fatigue in other patient populations, but this link has not been established in the ESRD population. Comparisons: The amount of muscle fatigue during intermittent submaximal quadriceps exercise between dialysis patients and controls will be compared. In addition, the degree of exercise-induced increase in markers of oxidative stress in muscle and in plasma will be compared between dialysis patients and controls and between dialysis patients who have received N-acetylcysteine for 6 days and those who have received placebo capsules.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTN-acetylcysteine600 mg po bid
DIETARY_SUPPLEMENTplacebobid oral dosing

Timeline

Start date
2007-03-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2007-02-27
Last updated
2010-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00440869. Inclusion in this directory is not an endorsement.